State of the art in the treatment of CLL "Estado da arte" no tratamento da leucemia linfocítica crônica
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults in the Western world and predominantly affects the elderly. Although CLL remains incurable with standard treatments, important progress in treatment, which classically is given only when the disease has become symptomat...
Main Author: | Teodoro Chisesi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-08-01
|
Series: | Revista Brasileira de Hematologia e Hemoterapia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842009000800014 |
Similar Items
-
Alemtuzumab (Campath-1H) para tratamento da leucemia linfóide crônica
by: Maria Kadma da Silva Carriço, et al.
Published: (2003-06-01) -
Eficácia e segurança do ofatumumabe versus ibrutinibe em pacientes com leucemia linfocítica crônica refratária: revisão sistemática
by: Karine Priscila Silva Andrade, et al.
Published: (2022-11-01) -
Estudo Referencial de um Protocolo Quimioterápico para Leucemia Linfocítica Aguda Infantil
by: Marcelino Oliveira Cazé, et al.
Published: (2010-04-01) -
Leucemia linfocítica aguda
by: Tor Gunnar Hugo Onsten, et al.
Published: (2022-07-01) -
Rituximab en leucemia linfocítica crónica en recaída y anemia hemolítica autoinmune. Presentación de un caso Use of Rituximab in recurrent chronic lymphocytic leukemia and autoimmune hemolytic anemia. A case presentation
by: Lissete M. Izquierdo Cano, et al.
Published: (2010-08-01)